Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.

MLA

Mairinger, Severin, et al. “Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 61, no. 11, Nov. 2020, pp. 1650–57. EBSCOhost, https://doi.org/10.2967/jnumed.120.244038.

APA

Mairinger, S., Sake, J. A., Hernández Lozano, I., Filip, T., Sauberer, M., Stanek, J., Wanek, T., Ehrhardt, C., & Langer, O. (2020). Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 61(11), 1650–1657. https://doi.org/10.2967/jnumed.120.244038

Chicago

Mairinger, Severin, Johannes A Sake, Irene Hernández Lozano, Thomas Filip, Michael Sauberer, Johann Stanek, Thomas Wanek, Carsten Ehrhardt, and Oliver Langer. 2020. “Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 61 (11): 1650–57. doi:10.2967/jnumed.120.244038.